Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: Preliminary results

Journal of Cardiovascular Electrophysiology

Volumn 22, Issue 11, 2011, Pages 1266-1273

  Cakulev, Ivan ^a   Lacerda, Antonio E ^b   Khrestian, Celeen M ^a   Ryu, Kyungmoo ^a   Brown, Arthur M ^b   Waldo, Albert L ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b ChanTest Corporation   (United States)

Author keywords

atrial fibrillation; atrial flutter; cardioversion; pericarditis; vanoxerine

Indexed keywords

VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG BLOOD LEVEL; DRUG EFFECT; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART EXCITATION; HEART MUSCLE REFRACTORY PERIOD; NONHUMAN; PERICARDITIS; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA;

ADMINISTRATION, ORAL; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CARDIAC PACING, ARTIFICIAL; DISEASE MODELS, ANIMAL; DOGS; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; PERICARDITIS; PIPERAZINES; RECURRENCE; TIME FACTORS;

EID: 80755132195     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2011.02098.x     Document Type: Article

References (20)

1. Lacerda AE, Kuryshev YA, Yan G, Waldo AL, Brown AM,: Vanoxerine: Cellular mechanism of a new antiarrhythmic. J Cardiovasc Electrophysiol 2010; 21: 301-310.
2. Preti A,: Vanoxerine National Institute on Drug Abuse. Curr Opin Investig Drugs 2000; 1: 241-251.
3. Ingwersen SH, Mant TG, Larsen JJ,: Food intake increases the relative oral bioavailability of vanoxerine. Br J Clin Pharmacol 1993; 35: 308-310. (Pubitemid 23074059)
4. Matsumoto N, Khrestian CM, Ryu K, Lacerda AE, Brown AM, Waldo AL,: Vanoxerine, a new drug for terminating atrial fibrillation and flutter. J Cardiovasc Electrophysiol 2010; 21: 311-319.
5. Ingwersen SH, Snel S, Mant TG, Edwards D,: Nonlinear multiple-dose pharmacokinetics of the dopamine reuptake inhibitor vanoxerine. J Pharm Sci 1993; 82: 1164-1166. (Pubitemid 24004452)
6. Søgaard U, Michalow J, Butler B, Lund Laursen A, Ingersen SH, Skrumsager BK, Rafaelsen OJ,: A tolerance study of single and multiple dosing of the selective dopamine uptake inhibitor GBR 12909 in healthy subjects. Int Clin Psychopharmacol 1990; 5: 237-251.
7. Pagé PL, Plumb VJ, Okumura K, Waldo AL,: A new animal model of atrial flutter. J Am Coll Cardiol 1986; 8: 872-879. (Pubitemid 16023643)
8. Goldstein RN, Khrestian C, Carlsson L, Waldo AL,: Azd7009: A new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model. J Cardiovasc Electrophysiol 2004; 15: 1444-1450. (Pubitemid 40013678)
9. Goldstein RN, Ryu K, Khrestian C, van Wagoner DR, Waldo AL,: Prednisone prevents inducible atrial flutter in the canine sterile pericarditis model. J Cardiovasc Electrophysiol 2008; 19: 74-81.
10. Ingwersen SH,: Column liquid chromatographic assay of the dopamine reuptake inhibitor vanoxerine (GBR 12909) in human serum. J Chromatogr 1991; 571: 305-311.
11. Shimizu A, Nozaki A, Rudy Y, Waldo AL,: Onset of induced atrial flutter in the canine pericarditis model. J Am Coll Cardiol 1991; 17: 1223-1234.
12. Wagner ML, Lazzara R, Weiss RM, Hoffman BF,: Specialized conducting fibers in the interatrial band. Circ Res 1966; 18: 502-518.
13. Watson RM, Josephson ME,: Atrial flutter: I. Electrophysiologic substrates and modes of initiation and termination. Am J Cardiol 1980; 45: 732-741. (Pubitemid 10148853)
14. Waldo AI, Cooper TB,: Spontaneous onset of type I atrial flutter in patients. J Am Coll Cardiol 1996; 28: 707-712. (Pubitemid 26288654)
15. Waldo AL,: Pathogenesis of atrial flutter. J Cardiovasc Electrophysiol 1998; 9 (8 Suppl): S18-S25. (Pubitemid 28394712)
16. Olgin JE, Kalman JM, Saxon LA, Lee RJ, Lesh MD,: Mechanism of initiation of atrial flutter in humans: Site of unidirectional block and direction of rotation. J Am Coll Cardiol 1997; 29: 376-384. (Pubitemid 27059969)
17. Maintenance of sinus rhythm in patients with atrial fibrillation: An AFFIRM substudy of the first antiarrhythmic drug. J Am Coll Cardiol 2003; 42: 20-29.
18. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B,: Amiodarone to prevent recurrence of atrial fibrillation. Canadian trial of atrial fibrillation investigators. N Engl J Med 2000; 342: 913-920. (Pubitemid 30177051)
19. Chevalier P, Durand-Dubief A, Burri H, Cucherat M, Kirkorian G, Touboul P,: Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: A meta-analysis. J Am Coll Cardiol 2003; 41: 255-62. (Pubitemid 36092194)
20. Vassallo P, Trohman RG,: Prescribing amiodarone: An evidence-based review of clinical indications. JAMA 2007; 298: 1312-1322. (Pubitemid 47449439)